Titular de la autorización de comercialización · Estados Unidos
Pfizer Inc.
209 medicamentos en 1 país, como titular de la autorización y fabricante.
Cargando la página…
Cargando la página…
Titular de la autorización de comercialización · Estados Unidos
209 medicamentos en 1 país, como titular de la autorización y fabricante.
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos registrados a su nombre, primero los vigentes.
1–25 de 209
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| ABRILADA10mg/0.2ml | 20mg/0.4ml | 40mg/0.8ml · Injectable | Adalimumab | Estados Unidos | Comercializado | 2019 |
| Abrilada40mg/0.8ml · Injection | Adalimumab | Estados Unidos | Comercializado | 2019 |
| Abrilada10mg/0.2ml · Injection | Adalimumab | Estados Unidos | No comercializado | 2019 |
| Abrysvo120ug · Injection | Respiratory syncytial virus vaccines | Estados Unidos | Comercializado | 2023 |
| ACCUPRIL10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG BASE * · Tablet | Quinapril | Estados Unidos | No comercializado | 1991 |
| ACCURETIC12.5MG; 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 12.5MG; 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 25MG; 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness · Tablet | Hydrochlorothiazide, Quinapril | Estados Unidos | No comercializado | 1999 |
| ADRIAMYCIN PFS200mg/100ml | 2mg/ml · Injectable | Doxorubicin | Estados Unidos | No comercializado | 1991 |
| ALDACTAZIDE25mg; 25mg | 50mg; 50mg · Tablet | Hydrochlorothiazide, Spironolactone | Estados Unidos | Comercializado | 1961 |
| ALDACTONE100mg | 25mg | 50mg · Tablet | Spironolactone | Estados Unidos | Comercializado | 1960 |
| AROMASIN25mg · Tablet | Exemestane | Estados Unidos | Comercializado | 1999 |
| ARTHROTEC50mg; 0.2mg | 75mg; 0.2mg · Tablet, delayed release | Diclofenac, Misoprostol | Estados Unidos | Comercializado | 1997 |
| ATARAX100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 50MG **Federal Register · Tablet | Hydroxyzine | Estados Unidos | No comercializado | 1956 |
| AZULFIDINE500mg · Tablet | Sulfasalazine | Estados Unidos | Comercializado | 1950 |
| AZULFIDINE EN-TABS500mg · Tablet, delayed release | Sulfasalazine | Estados Unidos | Comercializado | 1950 |
| CALAN120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 80MG **Federal Register · Tablet | Verapamil | Estados Unidos | No comercializado | 1984 |
| CALAN SR120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended release | Verapamil | Estados Unidos | No comercializado | 1986 |
| CAMPTOSAR100mg/5ml (20mg/ml) | 300mg/15ml (20mg/ml) | 40mg/2ml (20mg/ml) · Injectable | Irinotecan | Estados Unidos | Comercializado | 1996 |
| CAVERJECT0.005mg/ml | 0.005mg/vial | 0.01mg/ml | 0.01mg/vial | 0.02mg/ml | 0.02mg/vial | 0.04mg/vial · Injectable | Alprostadil | Estados Unidos | Comercializado | 1995 |
| CAVERJECT IMPULSE0.01mg/vial | 0.02mg/vial · Injectable | Alprostadil | Estados Unidos | Comercializado | 2002 |
| CEFOBID10gm base/vial | 1gm base/vial | 2gm base/vial · Injectable | Cefoperazone | Estados Unidos | No comercializado | 1982 |
| CEFOBID IN PLASTIC CONTAINER20mg base/ml | 40mg base/ml · Injectable | Cefoperazone | Estados Unidos | No comercializado | 1986 |
| CIBINQO100mg | 200mg | 50mg · Tablet | Abrocitinib | Estados Unidos | Comercializado | 2022 |
| CLEOCIN100mg · Suppository | Clindamycin | Estados Unidos | Comercializado | 1999 |
| CLEOCIN75MG BASE/5ML | 75MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · For solution | Clindamycin palmitate | Estados Unidos | Comercializado | 1986 |
| CLEOCIN1% base · Swab | Clindamycin | Estados Unidos | No comercializado | 1980 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Estados Unidos | 209 | 208 | 1 | EmpresasTodos los medicamentos |
También en los registros de Brasil
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licencia: CC0
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licencia: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Pfizer Inc. en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaOtras empresas del mismo grupo.
Ordenados por su número de medicamentos.